Why HCQ and Ivermectin were removed from India’s Covid-19 treatment protocol

The Indian Council of Medical Research (ICMR) and the National Task Force on Covid-19 have dropped the use of Ivermectin and Hydroxychloroquine (HCQ) drugs from their revised guidelines for the treatment of the infection.

The decision was taken after experts found that these drugs have little to no effect on Covid-related mortality or clinical recovery of the patient.

“HCQ may be considered for removal from guideline, with recommendation to use with caution only in clinical trial setting (since there is some genuine uncertainty regarding the possible benefit for severe cases and in low dose),” said the document titled ‘considerations for exclusion of Ivermectin and Hydroxychloroquine from the clinical guidance for management of adult Covid-19 patients’.

Several clinical studies have shown the low mortality benefit for HCQ, said the document. In fact, when HCQ is administered with azithromycin, it increases the risk of adverse drug effect (ADE) in patients, experts said.

ALSO READ | India reports 29,616 new Covid-19 cases in 24 hours, recovery rate highest since March 2020

Studies also found there was no clarity on mortality benefit, no effect on length of hospital stay and recovery in case of Ivermectin.

Recommending that Ivermectin be dropped from the clinical guidance, experts cited 13 systematic reviews of which “7/13 showed mortality benefit, 4/13 no mortality benefit, 2/13 inconclusive/unclear.”

Additionally, there was a high risk of bias in many of the studies, particularly with the ones showing mortality benefit, as the level of certainty is low in them.

The recommendations were made at a meeting of the All India Institute of Medical Sciences (AIIMS) and the ICMR national task force for Covid-19 and the Joint Monitoring Group on August 20.

ALSO READ | Covid-19: Maharashtra govt tells medical oxygen manufacturers to maintain stock at 95% capacity

Meanwhile, cautioning that the upcoming festival season is a critical period, AIIMS-Delhi Director Dr Randeep Guleria said the next 6-8 weeks are going to be critical and the community has to come together to ensure people follow all Covid norms and aggressively encourage vaccination.

While the number of new Covid-19 cases are steadily declining across the country, the Union Health Ministry has advised states and UTs to keep a strict vigil as the country is still in the midst of the second surge of the pandemic.

WATCH | 67% Indians have developed Covid-19 antibodies: Fourth sero survey

Note: This article have been indexed to our site. We do not claim ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Their Alzheimer's Disease Didn't Worsen. Why? thumbnail

Their Alzheimer’s Disease Didn’t Worsen. Why?

Neurology > Alzheimer's Disease — Case reports find one healthy habit in common by Judy George, Deputy Managing Editor, MedPage Today February 3, 2023 Sustained vigorous exercise might have slowed disease progression in two patients with positive Alzheimer's biomarkers and mild cognitive impairment, two case reports suggested. At age 64, patient 1 was diagnosed with
Read More
COMMENT thumbnail

COMMENT

Joachim Nagel soll der 12. Präsident der Bundesbank werden. In der EZB wird er es nicht leicht haben, denn dort vertritt die Bank seit Jahren eine Minderheitsmeinung. Seine wichtigste Aufgabe wird es sein, nicht wie seine Vorgänger vorzeitig den Bettel hinzuschmeissen. Joachim Nagel soll neuer Präsident der Deutschen Bundesbank werden. Michael Probst / APDie Geschichte von…
Read More
Secretary Vilsack Convenes State Agriculture Leaders from the Colorado River Basin as Part of the Biden-Harris Administration’s Comprehensive Approach to Address Unprecedented Drought in the Region thumbnail

Secretary Vilsack Convenes State Agriculture Leaders from the Colorado River Basin as Part of the Biden-Harris Administration’s Comprehensive Approach to Address Unprecedented Drought in the Region

USDA Highlights Resources and Programs Available to Producers Impacted by Drought in the Colorado River Basin Denver, Colorado, March 23, 2023 – Agriculture Secretary Tom Vilsack today met with the leaders of the state Departments of Agriculture for the seven Colorado River Basin states (Arizona, California, Colorado, Nevada, New Mexico, Utah, and Wyoming) to discuss
Read More
80% With Diabetes Eligible for New Drugs, but Cost Is a Barrier thumbnail

80% With Diabetes Eligible for New Drugs, but Cost Is a Barrier

Please enable cookies. Error 1005 Ray ID: 7b5669a92b02f2ce • 2023-04-09 23:08:34 UTC What happened? The owner of this website (www.webmd.com) has banned the autonomous system number (ASN) your IP address is in (47583) from accessing this website. Was this page helpful? Thank you for your feedback! Cloudflare Ray ID: 7b5669a92b02f2ce • Your IP: 89.117.245.16 •
Read More
Index Of News
Total
0
Share